Cantor Fitzgerald Reiterates Overweight on SELLAS Life Sciences Gr, Maintains $3 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Li Watsek has reiterated an Overweight rating on SELLAS Life Sciences Gr (NASDAQ:SLS) and maintained a $3 price target.
September 07, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated an Overweight rating on SELLAS Life Sciences Gr, maintaining a $3 price target.
The reiteration of an Overweight rating by Cantor Fitzgerald indicates a positive outlook for SELLAS Life Sciences Gr. The maintained price target of $3 also suggests that the analyst believes the stock is undervalued. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100